Cassava Sciences

Halal Rating :
See Details
Last Price $18.86 Last updated:
Market Cap $883.05m
7D Change 11.27%
1 Year Change -54.79%

Company Overview

  • Pharmaceuticals: Other
  • Health Technology
  • Manufacturing
  • Pharmaceutical Preparation Manufacturing
Exchange NASDAQ
Next Earnings Date Nov. 7, 2023

Cassava Sciences, Inc., a clinical-stage biotechnology company, develops drugs for neurodegenerative diseases. The company is headquartered in Austin, Texas.

Use of Interest

Reporting Date Total Revenue Total Operating Expense Interest Income Interest Expense Interest Income Ratio Interest Expense Ratio
Dec. 31, 2022 $-0.0 $20.94m $1.55m $1.8m 86333.33% 8.61%

Company Impact

Help us evaluate Cassava Sciences's impact from a halal perspective. Vote on the most significant aspect and submit any considerations that we may have missed.

Justification for our Halal Rating

Recent News & Updates